First Header Logo Second Header Logo

Connection

Roger Royster to Amrinone

This is a "connection" page, showing publications Roger Royster has written about Amrinone.
Connection Strength

0.362
  1. Royster RL, Butterworth JF, Prielipp RC, Zaloga GP, Lawless SG, Spray BJ, Kon ND, Wallenhaupt SL, Cordell AR. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesth Analg. 1993 Oct; 77(4):662-72.
    View in: PubMed
    Score: 0.118
  2. Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone. Chest. 1992 Jan; 101(1):174-80.
    View in: PubMed
    Score: 0.105
  3. Prielipp RC, Butterworth JF, Zaloga GP, Robertie PG, Royster RL. Effects of amrinone on cardiac index, venous oxygen saturation and venous admixture in patients recovering from cardiac surgery. Chest. 1991 Apr; 99(4):820-5.
    View in: PubMed
    Score: 0.099
  4. Butterworth JF, Royster RL, Prielipp RC, Lawless ST, Wallenhaupt SL. Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial. Chest. 1993 Dec; 104(6):1660-7.
    View in: PubMed
    Score: 0.030
  5. Butterworth JF, Legault C, Royster RL, Hammon JW. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg. 1998 Mar; 86(3):461-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.